TY - JOUR
T1 - Japanese guidelines for adult asthma 2017
AU - The Japanese Society of Allergology
AU - Ichinose, Masakazu
AU - Sugiura, Hisatoshi
AU - Nagase, Hiroyuki
AU - Yamaguchi, Masao
AU - Inoue, Hiromasa
AU - Sagara, Hironori
AU - Tamaoki, Jun
AU - Tohda, Yuji
AU - Munakata, Mitsuru
AU - Yamauchi, Kohei
AU - Ohta, Ken
N1 - Publisher Copyright:
© 2016 Japanese Society of Allergology
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Adult bronchial asthma is characterized by chronic airway inflammation, and presents clinically with variable airway narrowing (wheezes and dyspnea) and cough. Long-standing asthma induces airway remodeling, leading to intractable asthma. The number of patients with asthma has increased; however, the number of patients who die of asthma has decreased (1.2 per 100,000 patients in 2015). The goal of asthma treatment is to enable patients with asthma to attain normal pulmonary function and lead a normal life, without any symptoms. A good relationship between physicians and patients is indispensable for appropriate treatment. Long-term management by therapeutic agents and elimination of the causes and risk factors of asthma are fundamental to its treatment. Four steps in pharmacotherapy differentiate between mild and intensive treatments; each step includes an appropriate daily dose of an inhaled corticosteroid, varying from low to high levels. Long-acting β2-agonists, leukotriene receptor antagonists, sustained-release theophylline, and long-acting muscarinic antagonist are recommended as add-on drugs, while anti-immunoglobulin E antibody and oral steroids are considered for the most severe and persistent asthma related to allergic reactions. Bronchial thermoplasty has recently been developed for severe, persistent asthma, but its long-term efficacy is not known. Inhaled β2-agonists, aminophylline, corticosteroids, adrenaline, oxygen therapy, and other approaches are used as needed during acute exacerbations, by choosing treatment steps for asthma in accordance with the severity of exacerbations. Allergic rhinitis, eosinophilic chronic rhinosinusitis, eosinophilic otitis, chronic obstructive pulmonary disease, aspirin-induced asthma, and pregnancy are also important issues that need to be considered in asthma therapy.
AB - Adult bronchial asthma is characterized by chronic airway inflammation, and presents clinically with variable airway narrowing (wheezes and dyspnea) and cough. Long-standing asthma induces airway remodeling, leading to intractable asthma. The number of patients with asthma has increased; however, the number of patients who die of asthma has decreased (1.2 per 100,000 patients in 2015). The goal of asthma treatment is to enable patients with asthma to attain normal pulmonary function and lead a normal life, without any symptoms. A good relationship between physicians and patients is indispensable for appropriate treatment. Long-term management by therapeutic agents and elimination of the causes and risk factors of asthma are fundamental to its treatment. Four steps in pharmacotherapy differentiate between mild and intensive treatments; each step includes an appropriate daily dose of an inhaled corticosteroid, varying from low to high levels. Long-acting β2-agonists, leukotriene receptor antagonists, sustained-release theophylline, and long-acting muscarinic antagonist are recommended as add-on drugs, while anti-immunoglobulin E antibody and oral steroids are considered for the most severe and persistent asthma related to allergic reactions. Bronchial thermoplasty has recently been developed for severe, persistent asthma, but its long-term efficacy is not known. Inhaled β2-agonists, aminophylline, corticosteroids, adrenaline, oxygen therapy, and other approaches are used as needed during acute exacerbations, by choosing treatment steps for asthma in accordance with the severity of exacerbations. Allergic rhinitis, eosinophilic chronic rhinosinusitis, eosinophilic otitis, chronic obstructive pulmonary disease, aspirin-induced asthma, and pregnancy are also important issues that need to be considered in asthma therapy.
KW - Definition of asthma
KW - Diagnosis of asthma
KW - Epidemiology of asthma
KW - Long-term management of asthma
KW - Management of asthma exacerbation
UR - http://www.scopus.com/inward/record.url?scp=85012008704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85012008704&partnerID=8YFLogxK
U2 - 10.1016/j.alit.2016.12.005
DO - 10.1016/j.alit.2016.12.005
M3 - Review article
C2 - 28196638
AN - SCOPUS:85012008704
VL - 66
SP - 163
EP - 189
JO - Allergology International
JF - Allergology International
SN - 1323-8930
IS - 2
ER -